Normative data for multiple breath washout outcomes in school-aged Caucasian children.
Journal
The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
02
07
2019
accepted:
10
12
2019
pubmed:
22
12
2019
medline:
22
6
2021
entrez:
22
12
2019
Statut:
epublish
Résumé
The multiple breath nitrogen washout (N N Analysis used 485 trials from 180 healthy Caucasian children aged from 6 to 18 years old. While LCI increased with age, this increase was negligible (0.04 units·year We report reference values for N
Sections du résumé
BACKGROUND
The multiple breath nitrogen washout (N
METHODS
N
RESULTS
Analysis used 485 trials from 180 healthy Caucasian children aged from 6 to 18 years old. While LCI increased with age, this increase was negligible (0.04 units·year
CONCLUSION
We report reference values for N
Identifiants
pubmed: 31862765
pii: 13993003.01302-2019
doi: 10.1183/13993003.01302-2019
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : CommentIn
Type : ErratumIn
Informations de copyright
Copyright ©ERS 2020.
Déclaration de conflit d'intérêts
Conflict of interest: P. Anagnostopoulou has nothing to disclose. Conflict of interest: P. Latzin reports personal fees from Gilead, Novartis, Polyphor, Santhera, Schwabe, Vertex, Vifor and Zambon, as well as grants from Vertex, outside the submitted work. Conflict of interest: R. Jensen has nothing to disclose. Conflict of interest: M. Stahl reports personal fees from Vertex Pharmaceuticals, outside the submitted work. Conflict of interest: A. Harper has nothing to disclose. Conflict of interest: S. Yammine has nothing to disclose. Conflict of interest: J. Usemann has nothing to disclose. Conflict of interest: R.E. Foong has nothing to disclose. Conflict of interest: B. Spycher has nothing to disclose. Conflict of interest: G.L. Hall reports grants from the NHMRC and the Australia and USA CF Foundation, and non-financial support (loan of equipment) from ndd, during the conduct of the study. Conflict of interest: F. Singer reports personal fees from Vertex and Novartis, outside the submitted work. Conflict of interest: S. Stanojevic has nothing to disclose. Conflict of interest: M.A. Mall reports grants from the German Federal Ministry of Education and Research (82DZL004A1) and the Einstein Foundation Berlin (EP-2017-393), during the conduct of the study, and personal fees advisory board work, consultancy and lectures from Boehringer Ingelheim and Vertex Pharmaceuticals, outside the submitted work. Conflict of interest: F. Ratjen reports grants and personal fees for consultancy from Vertex, plus personal fees for consultancy from Novartis, Bayer, Roche and Genetech, outside the submitted work. Conflict of interest: K.A. Ramsey has nothing to disclose.